India’s school education system is set for one of its most significant transformations in decades as the Central Board of ...
Penn-Trafford High School science teacher Ryan Tucek has spent years studying the lunar exploration of the 1970s. But, just ...
Day 9 of the Artemis II crewed mission to the Moon was spent preparing for reentry and landing, including by conducting a ...
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone ...
As he leads the U.S. delegation in Pakistan to try to reach a peace agreement with Iran, Vice President JD Vance’s longtime ...
XPRIZE is the recognized global leader in designing and executing large-scale competitions to solve humanity’s greatest ...
A new bill would expand on the state’s plans to introduce captive deer into the wild by cutting the Department of Wildlife ...
Sci-fi fans looking for a Netflix show to binge-watch over a weekend should watch these five series, all of which offer big ...
Pseudocyesis can be distinguished from related phenomena such as delusion of pregnancy (belief in being pregnant with no physical signs or symptoms), simulated pregnancy (a deliberate attempt to ...
Oklo execs sold $21M in stock on April 1 while Jim Cramer questioned profitability. The nuclear startup also missed earnings ...
DAVIE, FL / ACCESS Newswire / April 7, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO" or the "Company"), a clinical-stage biotechnology company, today announced its selection as a Qualified Team adva ...
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results